Free shipping on all orders over $ 500

SAR125844

Cat. No. M20606

All AbMole products are for research use only, cannot be used for human consumption.

SAR125844 Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Quality Control & Documentation
Biological Activity

SAR125844 is a potent intravenously active and highly selective MET kinase inhibitor, displaying nanomolar activity against the wild-type kinase (IC50 value of 4.2 nmol/L) and H1094Y, Y1235D, M1250T, L1195V, and D1228H kinase domain mutants (IC50 values of 0.22, 1.7, 6.5, 65, and 81 nmol/L, respectively).

Chemical Information
Molecular Weight 550.63
Formula C25H23FN8O2S2
CAS Number 1116743-46-4
Solubility (25°C) DMSO 11 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Eric Angevin, et al. Eur J Cancer. A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification

[2] Kohei Shitara, et al. Oncotarget. Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer

[3] Antonio Ugolini, et al. J Med Chem. Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844)

[4] Coumaran Egile, et al. Mol Cancer Ther. The selective intravenous inhibitor of the MET tyrosine kinase SAR125844 inhibits tumor growth in MET-amplified cancer

Related c-Met Products
Zurletrectinib

Zurletrectinib (ICP-723) is a potent tyrosine kinase inhibitor. Zurletrectinib serves as an antineoplastic agent. Zurletrectinib can used for research of TRK-mediated related diseases.
ABN401 

ABN401 is a highly potent and selective ATP-competitive c-MET inhibitor with an IC50 value of 10 nM.
(Z)-Semaxanib

(Z)-Semaxanib is a potent tyrosine kinase inhibitor.
MET kinase-IN-2 

MET kinase-IN-2 is a potent, selective, orally bioavailable MET kinase inhibitor with an IC50 of 7.4 nM.
BMS-817378

BMS-817378 is a potent and selective inhibitor of MET with IC50 of 1.7 nM.
  Catalog
Abmole Inhibitor Catalog




Keywords: SAR125844 supplier, c-Met, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.


 
Get to Know Us
Customer Support
Resources
Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.